Acute monocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
633
|
22
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Germ cell tumor
|
disease |
Neoplasms
|
Neoplastic Process
|
278
|
5
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Nervous System, Organic Arsenic Poisoning
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Arsenic Poisoning, Inorganic
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Miller Dieker syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
182
|
9
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Germ Cell Cancer
|
disease |
Neoplasms
|
Neoplastic Process
|
44
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cockayne Syndrome, Type I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
80
|
42
|
0.300 |
None |
1.000 |
1 |
|
2013 |
2013 |
Tumor of Rete Testis
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Embryonal Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
57
|
2
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neoplasms, Embryonal and Mixed
|
disease |
Neoplasms
|
Neoplastic Process
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Arsenic Induced Polyneuropathy
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Cancer, Embryonal and Mixed
|
disease |
Neoplasms
|
Neoplastic Process
|
15
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cancer, Embryonal
|
phenotype |
Neoplasms
|
Neoplastic Process
|
18
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Arsenic Encephalopathy
|
disease |
Nervous System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Ovarian Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
539
|
19
|
0.300 |
None |
|
0 |
|
|
|
Basal cell carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
108
|
109
|
0.300 |
None |
|
0 |
|
|
|
PITUITARY DWARFISM I
|
disease |
Musculoskeletal Diseases; Nervous System Diseases; Endocrine System Diseases
|
Congenital Abnormality
|
25
|
9
|
0.300 |
strong |
|
0 |
|
|
|
Neoplasm of uncertain or unknown behavior of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
29
|
|
0.300 |
None |
|
0 |
|
|
|
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2012 |
2012 |
Cockayne Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
85
|
11
|
0.130 |
None |
1.000 |
8 |
2
|
2008 |
2018 |
Carcinoma, Basal Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
557
|
91
|
0.110 |
None |
1.000 |
1 |
|
1995 |
1995 |
Ataxia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
868
|
68
|
0.110 |
None |
1.000 |
1 |
|
2016 |
2016 |
Leukopenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
440
|
153
|
0.110 |
None |
1.000 |
1 |
|
2014 |
2014 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.941 |
17 |
6
|
1998 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.941 |
17 |
6
|
1998 |
2019 |